Brain

PaxMedica Announces Gold Sponsorship of The BRAIN Foundation’s Synchrony Symposia 2023

TARRYTOWN, NY / ACCESSWIRE / October 10, 2023 / PaxMedica, Inc. (NASDAQ:PXMD), a clinical stage biopharmaceutical company focusing on the…

8 months ago

Philips and World Stroke Organization partner to improve access to high-quality stroke care

A stroke patient rushed into the hospital October 10, 2023 Two-year partnership focused on advocacy, education, and raising awareness of…

8 months ago

NeuraSignal’s NovaGuide™ Intelligent Ultrasound System Significantly Outperforms Standard of Care for Detecting Stroke-Associated Heart Defects

—Data published in Stroke show that NovaGuide was about three times more likely to detect right to left shunt (RLS)…

8 months ago

Safety Shot’s Chief Operating Officer Jarrett Boon Joins Company’s Board of Directors

JUPITER, FL, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) today announced that Jarrett Boon, who has…

8 months ago

Cerevance to Participate at the 3rd Annual Needham Biotech Private Company Forum

BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing precision…

8 months ago

Aruna Bio to Participate in the BIO Investor Forum in October 2023

BOSTON and ATHENS, Ga., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural…

8 months ago

Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit

NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines…

8 months ago

Stem Pharm and Verge Genomics Form Collaboration Focused on Parkinson’s Disease

MADISON, Wis., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Stem Pharm, Inc., a drug discovery platform company leveraging 3D neuro-immune organoids…

8 months ago

Taysha Gene Therapies Announces Two Poster Presentations on TSHA-102 in Rett Syndrome at Upcoming European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress

DALLAS, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on…

8 months ago

IRLAB Signs Phase III Regulatory US Consultants to Support Preparation for Mesdopetam’s end-of-Phase 2 Meeting with the US FDA

GOTHENBURG, SWEDEN / ACCESSWIRE / October 10, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company…

8 months ago